These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20890651)

  • 1. Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient.
    Wallis CL; Venter WD; Stevens WS; Papathanasopoulos MA
    Virus Genes; 2010 Dec; 41(3):358-60. PubMed ID: 20890651
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report of a novel amino acid deletion in codon 67 and T69G substitution in the reverse transcriptase of HIV-1.
    Giri J; Rueda HJ; Monticelli A; Planes N
    Antivir Ther; 2000 Sep; 5(3):227-8. PubMed ID: 11075943
    [No Abstract]   [Full Text] [Related]  

  • 3. Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations.
    Saravanan S; Madhavan V; Kantor R; Sivamalar S; Gomathi S; Solomon SS; Kumarasamy N; Smith DM; Schooley RT; Solomon S; Balakrishnan P
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1763-5. PubMed ID: 22404052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.
    Antinori A; Liuzzi G; Cingolani A; Bertoli A; Di Giambenedetto S; Trotta MP; Rizzo MG; Girardi E; De Luca A; Perno CF
    AIDS; 2001 Nov; 15(17):2325-7. PubMed ID: 11698709
    [No Abstract]   [Full Text] [Related]  

  • 5. [CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77I in protease and/or A62V in reverse transcriptase].
    Selimova LM; Serebrovskaia LV; Ivanova LA; Nosik DN
    Vopr Virusol; 2010; 55(2):22-6. PubMed ID: 20455467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of HIV-1 variants containing codon insertions and deletions in the beta3-beta4 hairpin loop domain of reverse transcriptase.
    Kaliki V; Day NK; Dinglasan E; James-Yarish M; Hitchcock R; Skapura D; Chinta A; Johnson L; Andreopoulos A; Rey A; Good RA; Haraguchi S
    Immunol Lett; 2000 Oct; 74(2):173-5. PubMed ID: 10996393
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1 reverse transcriptase nucleotide substitutions in subtype C-infected, drug-naive, and treatment-experienced patients in South India.
    Saravanan S; Madhavan V; Balakrishnan P; Solomon SS; Kumarasamy N; Mayer KH; Waldrop G; Solomon S; Smith DM
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e94-5. PubMed ID: 21876445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel codon insert in protease of clade B HIV type 1.
    Jordan PS; Poon A; Eron J; Squires K; Ignacio C; Richman DD; Smith DM
    AIDS Res Hum Retroviruses; 2009 May; 25(5):547-50. PubMed ID: 19397401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles.
    Imamichi T; Murphy MA; Imamichi H; Lane HC
    J Virol; 2001 Apr; 75(8):3988-92. PubMed ID: 11264389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients.
    Geretti AM; Smith M; Osner N; O'Shea S; Chrystie I; Easterbrook P; Zuckerman M
    AIDS; 2001 May; 15(8):1082-4. PubMed ID: 11400002
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.
    Suzuki K; Kaufmann GR; Mukaide M; Cunningham P; Harris C; Leas L; Kondo M; Imai M; Pett SL; Finlayson R; Zaunders J; Kelleher A; Cooper DA
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1293-6. PubMed ID: 11559430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.
    Goudsmit J; De Ronde A; Ho DD; Perelson AS
    J Virol; 1996 Aug; 70(8):5662-4. PubMed ID: 8764084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the near full-length genome of an HIV type 1 A1/C unique recombinant form from northern South Africa.
    Iweriebor BC; Bessong PO; Mavhandu LG; Masebe TM; Nwobegahay J; Moyo SR; Mphahlele JM
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):911-5. PubMed ID: 21087143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcriptase fidelity and HIV-1 variation.
    Balzarini J; Pelemans H; De Clercq E; Karlsson A; Kleim JP
    Science; 1997 Jan; 275(5297):229-30; author reply 230-1. PubMed ID: 8999551
    [No Abstract]   [Full Text] [Related]  

  • 17. Reverse transcriptase fidelity and HIV-1 variation.
    Preston BD
    Science; 1997 Jan; 275(5297):228-9; author reply 230-1. PubMed ID: 8999549
    [No Abstract]   [Full Text] [Related]  

  • 18. Reverse transcriptase fidelity and HIV-1 variation.
    Keulen W; Nijhuis M; Schuurman R; Berkhout B; Boucher C
    Science; 1997 Jan; 275(5297):229; author reply 230-1. PubMed ID: 8999550
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexistence of HIV-1 variants with dipeptidic insertion in the reverse transcriptase gene.
    Tanikawa AA; Barreto SF; Grotto RM; Pardini MI
    Rev Saude Publica; 2013 Aug; 47(4):821-3. PubMed ID: 24346670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
    J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.